PRKAB1 and cancer: Pharmacological activation of AMPK using AICAR or metformin can inhibit the growth or induce apoptosis of a wide spectrum of cancer cells, including cervical [5] and ovarian [6-8] cancers, through modulation of p53, p27, or p21 activities and cellular activities such as cell polarity and mitosis [2,3,9]